Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
2.8%
% of VHT's 417 holdings also in OZEM
47.8%
% of OZEM's 23 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.0% | 14.2% | 10.0% |
|
AMGEN INC | 2.5% | 3.2% | 2.5% |
|
PFIZER INC | 2.3% | 3.0% | 2.3% |
|
REGENERON PHARMACEUTICALS | 1.4% | 2.3% | 1.4% |
|
VIKING THERAPEUTICS, INC. | 0.1% | 3.3% | 0.1% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 9.1% |
|
JOHNSON & JOHNSON | 4.7% |
|
ABBVIE INC | 4.4% |
|
MERCK & CO. INC. | 3.9% |
|
ABBOTT LABORATORIES | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
DANAHER CORP | 2.6% |
|
STRYKER CORP | 2.2% |
|
BOSTON SCIENTIFIC CORP | 2.1% |
VHT Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.9% |
 |
ROCHE HOLDING LTD | -4.9% |
|
ZEALAND PHARMA A/S | -4.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ALTIMMUNE, INC. | -4.6% |
|
ELI LILLY & CO | -4.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.3% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |